{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T15:04:26Z","timestamp":1776006266306,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Vivozon Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s40263-025-01181-9","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T14:53:34Z","timestamp":1744728814000},"page":"583-595","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of Safety, Pharmacokinetic, and Pharmacodynamic Characteristics of a Novel Dual mGluR5\/5-HT2AR Antagonist (VVZ-2471) in a Randomized, Double-Blind, First-in-Human Study"],"prefix":"10.1007","volume":"39","author":[{"given":"Sungyeun","family":"Bae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HyunJoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inkyung","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jina","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Rim","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunyoung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Sang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4188-2786","authenticated-orcid":false,"given":"Jae-Yong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"1181_CR1","volume-title":"Back in the national spotlight: an assessment of recent changes in drug use and drug policies in the United States","author":"B Kilmer","year":"2015","unstructured":"Kilmer B, Midgette G, Saloga C. Back in the national spotlight: an assessment of recent changes in drug use and drug policies in the United States. Washington DC: Brookings Institute; 2015."},{"key":"1181_CR2","unstructured":"World Health Organization. Global status report on alcohol and health and treatment of substance use disorders. Alcohol Drugs Addict Behav (ADA). 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240096745. Accessed 11 Mar 2025."},{"issue":"4","key":"1181_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1056\/NEJMra1604339","volume":"375","author":"MA Schuckit","year":"2016","unstructured":"Schuckit MA. Treatment of opioid-use disorders. N Engl J Med. 2016;375(4):357\u201368.","journal-title":"N Engl J Med"},{"key":"1181_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0079-6123(08)00916-3","volume":"172","author":"MJ Bubar","year":"2008","unstructured":"Bubar MJ, Cunningham KA. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse. Prog Brain Res. 2008;172:319\u201346.","journal-title":"Prog Brain Res"},{"key":"1181_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fphar.2011.00093","volume":"2","author":"RM Cleva","year":"2012","unstructured":"Cleva RM, Watterson LR, Johnson MA, Olive MF. Differential modulation of thresholds for intracranial self-stimulation by mGlu5 positive and negative allosteric modulators: implications for effects on drug self-administration. Front Pharmacol. 2012;2:93.","journal-title":"Front Pharmacol"},{"issue":"2","key":"1181_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/sj.npp.1300819","volume":"31","author":"EA Pehek","year":"2006","unstructured":"Pehek EA, Nocjar C, Roth BL, Byrd TA, Mabrouk OS. Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex. Neuropsychopharmacology. 2006;31(2):265\u201377.","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"1181_CR7","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1111\/j.1471-4159.2005.03485.x","volume":"95","author":"A Bortolozzi","year":"2005","unstructured":"Bortolozzi A, D\u00edaz-Mataix L, Scorza MC, Celada P, Artigas F. The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. J Neurochem. 2005;95(6):1597\u2013607.","journal-title":"J Neurochem"},{"issue":"3","key":"1181_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0893-133X(01)00333-5","volume":"26","author":"G Porras","year":"2002","unstructured":"Porras G, Di Matteo V, Fracasso C, Lucas G, De Deurwaerd\u00e8re P, Caccia S, et al. 5-HT2A and 5-HT2C\/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology. 2002;26(3):311\u201324.","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"1181_CR9","first-page":"576","volume":"27","author":"PJ Fletcher","year":"2002","unstructured":"Fletcher PJ, Grottick AJ, Higgins GA. Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology. 2002;27(4):576\u201386.","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"1181_CR10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s00213-002-1104-4","volume":"162","author":"PJ Fletcher","year":"2002","unstructured":"Fletcher PJ, Korth KM, Robinson SR, Baker GB. Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement. Psychopharmacology. 2002;162(3):282\u201391.","journal-title":"Psychopharmacology"},{"issue":"3","key":"1181_CR11","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1124\/jpet.104.068841","volume":"310","author":"M Filip","year":"2004","unstructured":"Filip M, Bubar MJ, Cunningham KA. Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses. J Pharmacol Exp Ther. 2004;310(3):1246\u201354.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"1181_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1021\/cn300072u","volume":"4","author":"KA Cunningham","year":"2013","unstructured":"Cunningham KA, Anastasio NC, Fox RG, Stutz SJ, Bubar MJ, Swinford SE, et al. Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addiction. ACS Chem Neurosci. 2013;4(1):110\u201321.","journal-title":"ACS Chem Neurosci"},{"issue":"3","key":"1181_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0893-133X(00)00206-2","volume":"24","author":"LR McMahon","year":"2001","unstructured":"McMahon LR, Cunningham KA. Role of 5-HT(2a) and 5-HT(2B\/2C) receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors. Neuropsychopharmacology. 2001;24(3):319\u201329.","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"1181_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrn2515","volume":"10","author":"PW Kalivas","year":"2009","unstructured":"Kalivas PW. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci. 2009;10(8):561\u201372.","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"1181_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1124\/mol.104.003319","volume":"67","author":"MF Olive","year":"2005","unstructured":"Olive MF, McGeehan AJ, Kinder JR, McMahon T, Hodge CW, Janak PH, et al. The mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine decreases ethanol consumption via a protein kinase C epsilon-dependent mechanism. Mol Pharmacol. 2005;67(2):349\u201355.","journal-title":"Mol Pharmacol"},{"issue":"12","key":"1181_CR16","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1038\/aps.2014.93","volume":"35","author":"ZZ Lou","year":"2014","unstructured":"Lou ZZ, Chen LH, Liu HF, Ruan LM, Zhou WH. Blockade of mGluR5 in the nucleus accumbens shell but not core attenuates heroin seeking behavior in rats. Acta Pharmacol Sin. 2014;35(12):1485\u201392.","journal-title":"Acta Pharmacol Sin"},{"issue":"11","key":"1181_CR17","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1007\/s00213-024-06634-5","volume":"241","author":"LF Vendruscolo","year":"2024","unstructured":"Vendruscolo LF, Vendruscolo JCM, Whiting KE, Acri JB, Volkow ND, Koob GF. The mGlu5 receptor negative allosteric modulator mavoglurant reduces escalated cocaine self-administration in male and female rats. Psychopharmacology. 2024;241(11):2303\u201313.","journal-title":"Psychopharmacology"},{"key":"1181_CR18","unstructured":"U.S. Food and Drug Administration. Guidance for industry: estimating the maximum safe starting dose in adult healthy volunteer. 2005."},{"key":"1181_CR19","doi-asserted-by":"crossref","unstructured":"Beck AT, Steer RA, Brown G. Beck depression inventory\u2014II. Psychological assessment. 1996.","DOI":"10.1037\/t00742-000"},{"issue":"1","key":"1181_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/14622200020032051","volume":"3","author":"LS Cox","year":"2001","unstructured":"Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res. 2001;3(1):7\u201316.","journal-title":"Nicotine Tob Res"},{"issue":"4","key":"1181_CR21","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.pbb.2011.04.010","volume":"100","author":"C Riaza Bermudo-Soriano","year":"2012","unstructured":"Riaza Bermudo-Soriano C, Perez-Rodriguez MM, Vaquero-Lorenzo C, Baca-Garcia E. New perspectives in glutamate and anxiety. Pharmacol Biochem Behav. 2012;100(4):752\u201374.","journal-title":"Pharmacol Biochem Behav"},{"key":"1181_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fnins.2011.00040","volume":"5","author":"LA Blackshaw","year":"2011","unstructured":"Blackshaw LA, Page AJ, Young RL. Metabotropic glutamate receptors as novel therapeutic targets on visceral sensory pathways. Front Neurosci. 2011;5:40.","journal-title":"Front Neurosci"},{"issue":"10","key":"1181_CR23","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/j.1532-2149.2013.00327.x","volume":"17","author":"J Kalliom\u00e4ki","year":"2013","unstructured":"Kalliom\u00e4ki J, Huizar K, K\u00e5gedal M, H\u00e4ggl\u00f6f B, Schmelz M. Evaluation of the effects of a metabotropic glutamate receptor 5-antagonist on electrically induced pain and central sensitization in healthy human volunteers. Eur J Pain. 2013;17(10):1465\u201371.","journal-title":"Eur J Pain"},{"issue":"10","key":"1181_CR24","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1111\/j.1365-2036.2012.05081.x","volume":"35","author":"WO Rohof","year":"2012","unstructured":"Rohof WO, Lei A, Hirsch DP, Ny L, Astrand M, Hansen MB, et al. The effects of a novel metabotropic glutamate receptor 5 antagonist (AZD2066) on transient lower oesophageal sphincter relaxations and reflux episodes in healthy volunteers. Aliment Pharmacol Ther. 2012;35(10):1231\u201342.","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"1181_CR25","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/j.1365-2036.2011.04596.x","volume":"33","author":"F Zerbib","year":"2011","unstructured":"Zerbib F, Bruley des Varannes S, Roman S, Tutuian R, Galmiche JP, Mion F, et al. Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011;33(8):911\u201321.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1181_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/cpt.2903","volume":"114","author":"CA Bousman","year":"2023","unstructured":"Bousman CA, Stevenson JM, Ramsey LB, Sangkuhl K, Hicks JK, Strawn JR, et al. Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants. Clin Pharmacol Ther. 2023;114(1):51\u201368.","journal-title":"Clin Pharmacol Ther"},{"issue":"188","key":"1181_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.brainresbull.2022.07.017","volume":"1","author":"JM Yingst","year":"2022","unstructured":"Yingst JM, Lester C, Livelsberger C, Allen SI, Hammett E, Veldheer S, et al. Pilot randomized controlled trial evaluating the effect of random nicotine delivery on cigarettes per day and smoke exposure. Brain Res Bull. 2022;1(188):30\u20137.","journal-title":"Brain Res Bull"},{"issue":"2\u20133","key":"1181_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.schres.2016.08.016","volume":"176","author":"DW Jeon","year":"2016","unstructured":"Jeon DW, Shim JC, Kong BG, Moon JJ, Seo YS, Kim SJ, et al. Adjunctive varenicline treatment for smoking reduction in patients with schizophrenia: a randomized double-blind placebo-controlled trial. Schizophr Res. 2016;176(2\u20133):206\u201311.","journal-title":"Schizophr Res"},{"issue":"4","key":"1181_CR29","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.bmc.2005.09.011","volume":"14","author":"LM Espinoza-Fonseca","year":"2006","unstructured":"Espinoza-Fonseca LM. The benefits of the multi-target approach in drug design and discovery. Bioorg Med Chem. 2006;14(4):896\u20137.","journal-title":"Bioorg Med Chem"},{"key":"1181_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fphar.2015.00205","volume":"6","author":"A Talevi","year":"2015","unstructured":"Talevi A. Multi-target pharmacology: possibilities and limitations of the \u201cskeleton key approach\u201d from a medicinal chemist perspective. Front Pharmacol. 2015;6:205.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1181_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40169-017-0181-2","volume":"7","author":"RR Ramsay","year":"2018","unstructured":"Ramsay RR, Popovic-Nikolic MR, Nikolic K, Uliassi E, Bolognesi ML. A perspective on multi-target drug discovery and design for complex diseases. Clin Transl Med. 2018;7(1):3.","journal-title":"Clin Transl Med"},{"issue":"9\u201310","key":"1181_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.drudis.2012.01.003","volume":"17","author":"MH Pang","year":"2012","unstructured":"Pang MH, Kim Y, Jung KW, Cho S, Lee DH. A series of case studies: practical methodology for identifying antinociceptive multi-target drugs. Drug Discov Today. 2012;17(9\u201310):425\u201334.","journal-title":"Drug Discov Today"},{"issue":"9","key":"1181_CR33","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1093\/pm\/pnab066","volume":"22","author":"I Song","year":"2021","unstructured":"Song I, Cho S, Nedeljkovic SS, Lee SR, Lee C, Kim J, et al. Role of VVZ-149, a novel analgesic molecule, in the affective component of pain: results from an exploratory proof-of-concept study of postoperative pain following laparoscopic and robotic-laparoscopic gastrectomy. Pain Med. 2021;22(9):2037\u201349.","journal-title":"Pain Med"},{"key":"1181_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2021.110576","volume":"76","author":"SS Nedeljkovic","year":"2022","unstructured":"Nedeljkovic SS, Song I, Bao X, Zeballos JL, Correll DJ, Zhang Y, et al. Exploratory study of VVZ-149, a novel analgesic molecule, in the affective component of acute postoperative pain after laparoscopic colorectal surgery. J Clin Anesth. 2022;76: 110576.","journal-title":"J Clin Anesth"}],"updated-by":[{"DOI":"10.1007\/s40263-026-01279-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000}}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01181-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-025-01181-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01181-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:36:32Z","timestamp":1772174192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-025-01181-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1181"],"URL":"https:\/\/doi.org\/10.1007\/s40263-025-01181-9","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"16 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The correct IC<sub>50<\/sub> values for VVZ-2471 have been updated.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40263-026-01279-8","URL":"https:\/\/doi.org\/10.1007\/s40263-026-01279-8","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was sponsored by Vivozon Inc., Republic of Korea.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Jina Kim, Sang Rim Lee, Inkyung Song, and Sunyoung Cho are employees of Vivozon Inc. The other authors declare no competing interests for this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Jae-Yong Chung is the guarantor of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The study was approved by the Institutional Review Board of Seoul National University Bundang Hospital (IRB no. B-2207-770-003) and was conducted in accordance with the Declaration of Helsinki and Korean Good Clinical Practice.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all participants before enrollment in the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Jae-Yong Chung was the principal investigator who collected data and Kyung-Sang Yu was the main supervisor of the study. HyunJoon Lee, Jina Kim, and Sang Rim Lee contributed to the study plan revision and supervision. Sungyeun Bae, Inkyung Song, and Sungyoung Cho contributed to manuscript writing. All authors revised the manuscript.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}